학술논문

Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS) as first-line therapy in patients with advanced gastro-esophageal cancer.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2015, 33 15, 1p. Supplement: S
Subject
Language
English
ISSN
15277755